Events

TIAFT joint session with IATDMCT. Martinique, June 6, 2008

AACC-IATDMCT Joint Symposium LC/MS and LC MS/MS in Clinical and Forensic Toxicology, Jul 26, 2008 Registration form



 

International Conference Therapeutic drug monitoring in optimizing immunosuppressive therapy. Warsaw, Poland, September 26-27, 2008

Login

Forgot Password

Our aims are:

  • To promote the knowledge and understanding of clinical drug analysis and interpretation of results.

 

  • To enhance communication between scientists and physicians of all disciplines involved in therapeutic drug monitoring and clinical toxicology.

 

  • To encourage the effective application of therapeutic drug monitoring and clinical toxicology; with the aim of optimizing clinical drug use and maximizing the clinical and economic benefits.

 

Application form (PDF) (Word)

Journal

IATDMCT is assuming ownership of Therapeutic Drug Monitoring journal

IATDMCT members have free on-line access to the journal Therapeutic Drug Monitoring.

IFCC-IATDMCT Working Group on Immunosuppressive Drug Monitoring Workshop and Annual General meeting, Los Angeles, July 2004


Faculty from the IFCC-IATDMCT Working Group on Immunosuppressive Drug Monitoring Workshop.From left to right): Prof Gilbert Burckhart, University of Southern California, Los Angeles, USA, Prof Les Shaw, University of Pennsylvania, Philadelphia, USA, Dr. Belinda Yen-Lieberman, Cleveland Clinic, Cleveland, USA, Dr. David Holt, St. George's Hospital Medical School, London, UK, Dr. Ray Morris, Queen Elizabeth Hospital, Woodville, Australia


Dr. Steven Soldin, President


Dr. M. Linder


Dr. I. Watson


Mrs. L. Hooper


Dr. D. Holt


Dr. Ray Morris


Dr. Steven Soldin, President


Dr. Michael Oellerich


AGM attendees

Notice for the working group meeting

AGM

Dr. Morris and Dr. Holt

Powered By Dragonfly IT Ltd.